Xylem (NYSE:XYL) Stock Gets Price Target Reduction from BNP Paribas Exane

Xylem (NYSE:XYL) had its price target decreased by BNP Paribas Exane from $145.00 to $135.00 in a report published on Wednesday,Benzinga reports. BNP Paribas Exane currently has an outperform rating on the industrial products company’s stock.

Several other equities research analysts have also recently weighed in on XYL. JPMorgan Chase & Co. cut shares of Xylem from an “overweight” rating to a “neutral” rating and lowered their price objective for the company from $118.00 to $90.00 in a research report on Wednesday. Wolfe Research assumed coverage on Xylem in a research note on Tuesday, September 15th. They issued a “peer perform” rating for the company. Oppenheimer decreased their target price on shares of Xylem from $150.00 to $135.00 and set an “outperform” rating for the company in a research report on Wednesday. Weiss Ratings restated a “hold (c)” rating on shares of Xylem in a research note on Wednesday, August 5th. Finally, UBS Group dropped their price objective on Xylem from $138.00 to $112.00 and set a “neutral” rating for the company in a report on Monday, October 5th. Nine analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Xylem presently has a consensus rating of “Hold” and an average price target of $121.31.

Xylem Stock Performance

NYSE XYL opened at $92.41 on Wednesday. The company has a market cap of $21.19 billion, a PE ratio of 20.44, a price-to-earnings-growth ratio of 1.51 and a beta of 1.00. Xylem has a 1-year low of $87.40 and a 1-year high of $152.43. The stock’s 50 day simple moving average is $105.05 and its 200-day simple moving average is $117.57. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.39 and a quick ratio of 1.24.

Xylem (NYSE:XYL) last released its earnings results on Tuesday, October 27th. The industrial products company reported $1.44 EPS for the quarter, missing analysts’ consensus estimates of $1.45 by ($0.01). Xylem had a net margin of 11.94% and a return on equity of 12.06%. The business had revenue of $2.20 billion during the quarter, compared to analyst estimates of $2.28 billion. During the same period last year, the business posted $1.37 EPS. Xylem’s revenue was down 3.0% compared to the same quarter last year. As a group, equities research analysts anticipate that Xylem will post 5.45 EPS for the current fiscal year.

Xylem Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 24th. Stockholders of record on Thursday, August 27th were issued a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date was Thursday, August 27th. Xylem’s dividend payout ratio (DPR) is 40.95%.

Insiders Place Their Bets

In other news, Director D Koch acquired 11,000 shares of the business’s stock in a transaction dated Thursday, October 29th. The stock was acquired at an average price of $89.60 per share, for a total transaction of $985,600.00. Following the completion of the acquisition, the director directly owned 12,247 shares in the company, valued at $1,097,331.20. This represents a 882.12% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. 0.32% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the company. Jmac Enterprises LLC bought a new position in shares of Xylem during the 3rd quarter worth about $537,000. Covestor Ltd boosted its holdings in Xylem by 38.5% during the 3rd quarter. Covestor Ltd now owns 583 shares of the industrial products company’s stock valued at $59,000 after acquiring an additional 162 shares during the period. Markel Group Inc. purchased a new position in shares of Xylem in the third quarter worth about $1,244,000. Putney Financial Group LLC purchased a new position in Xylem in the 3rd quarter valued at about $73,000. Finally, Mountain Pacific Investment Advisers LLC increased its holdings in Xylem by 5.5% in the 3rd quarter. Mountain Pacific Investment Advisers LLC now owns 141,766 shares of the industrial products company’s stock valued at $14,357,000 after purchasing an additional 7,403 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors.

Xylem News Roundup

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: Director D. Christian Koch purchased 11,000 Xylem shares for approximately $985,600 at an average price of $89.60. The transaction increased his direct holdings more than eightfold and may signal confidence that the recent selloff has created an attractive entry point. Insider purchase report
• Positive Sentiment: Some analysts continue to see longer-term value. RBC Capital reaffirmed its buy rating, while RBC’s new coverage assigned a moderate-buy rating and a $125 price target, implying substantial upside from recent levels. RBC rating report
• Neutral Sentiment: Xylem announced divestitures and a new three-segment operating structure. The changes could sharpen strategic focus and improve portfolio efficiency, but execution and transition risks remain. Xylem restructuring report
• Negative Sentiment: Xylem’s latest quarter missed expectations: EPS was $1.44 versus $1.45 expected, revenue was $2.20 billion versus $2.28 billion expected, and sales declined 3% year over year. Management’s new 2026 adjusted-EPS ceiling of $5.45 is below the prior $5.55 floor, reinforcing concerns about weaker growth.
• Negative Sentiment: Barclays downgraded Xylem to equal weight from overweight, JPMorgan lowered its rating to underweight, and UBS, Stifel, BNP Paribas Exane, Citigroup and Oppenheimer reduced price targets. The revisions reflect diminished near-term earnings and valuation expectations. Barclays downgrade report
• Negative Sentiment: Levi & Korsinsky announced an investigation into potential securities-law violations related to investor losses, adding legal uncertainty and another possible overhang for XYL shareholders. Investigation announcement

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.